120 Participants NeededMy employer runs this trial

Medi-TBS for Depression

JM
Overseen ByJyoti Mishra, PhD
Age: 18+
Sex: Any
Trial Phase: Phase 2
Sponsor: University of California, San Diego
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)
Prior Safety DataThis treatment has passed at least one previous human trial

What You Need to Know Before You Apply

What is the purpose of this trial?

Repetitive Transcranial Magnetic stimulation (rTMS) is an FDA-approved therapy for treatment resistant depression (TRD) that involves brief magnetic stimulation pulses on the dorsolateral prefrontal cortex (DLPFC) brain region. But studies of rTMS alone show remission rates of \~30%. Additionally, rTMS has not been shown to improve cognitive functioning that may be an independent factor predicting treatment success. This study will develop a novel multimodal treatment, which combines intermittent theta burst stimulation (iTBS) - a type of rTMS with digital mindfulness training to engage brain plasticity, enhance cognition and alleviate depression symptoms in individuals with TRD.

Are You a Good Fit for This Trial?

Inclusion Criteria

I am able to understand and agree to participate in the study.
I have tried at least one antidepressant that did not work for me.
* Montgomery-Åsberg Depression Rating Scale (MADRS) Score \>19 (moderate - severe depression).
See 2 more

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Treatment

Participants receive a multimodal treatment combining iTBS and digital mindfulness training for 20 sessions over 4 weeks

4 weeks
20 sessions (in-person)

Follow-up

Participants are monitored for changes in depression symptoms and cognitive function

8 weeks

What Are the Treatments Tested in This Trial?

Interventions

  • Medi-TBS

How Is the Trial Designed?

2

Treatment groups

Experimental Treatment

Active Control

Group I: Medi1-TBSExperimental Treatment1 Intervention
Group II: Medi3-TBSActive Control1 Intervention

Find a Clinic Near You

Who Is Running the Clinical Trial?

University of California, San Diego

Lead Sponsor

Trials
1,215
Recruited
1,593,000+